These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 782112)

  • 1. [Effect of antitissue serum antibodies cross reacting with microbial antigens on the course of the infectious process].
    Ogurtsov RP
    Zh Mikrobiol Epidemiol Immunobiol; 1976 Jun; (6):21-6. PubMed ID: 782112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of cross-reacting microbial antigens and antibodies on the allograft rejection reaction.
    Ogurtsov RP
    Bull Exp Biol Med; 1974 Nov; 77(5):542-4. PubMed ID: 4613404
    [No Abstract]   [Full Text] [Related]  

  • 3. [Effect of antibodies, cross reacting with microbial and tissue antigens, on the cytotoxic activity of sensitized lymphocytes].
    Ogurtsov RP
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Jul; (7):128-32. PubMed ID: 4616574
    [No Abstract]   [Full Text] [Related]  

  • 4. [Significance of passive sensitization by cross-reacting antibodies and of active immunization by cross-reacting microbial antigens for the development of an immunopathologic process].
    Ogurtsov RP
    Vestn Akad Med Nauk SSSR; 1974; (11):30-4. PubMed ID: 4615469
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of allogenic skin transplantation on formation of antibodies to tissue and cross-reacting microbial antigens].
    Ogurtosov RP
    Zh Mikrobiol Epidemiol Immunobiol; 1974 Feb; (2):128-32. PubMed ID: 4616562
    [No Abstract]   [Full Text] [Related]  

  • 6. [Induction of autologous tissue disorders in animals tolerant to cross-reacting microbial antigens].
    Ogurtsov RP
    Zh Mikrobiol Epidemiol Immunobiol; 1975 Jun; (6):52-6. PubMed ID: 1098337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cytotoxic activity of lymphocytes from mice sensitized to cross reacting microbial antigens].
    Ogurtsov RP
    Biull Eksp Biol Med; 1973 May; 75(5):60-3. PubMed ID: 4591630
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunoblot analyses of Candida albicans-associated antigens and antibodies in human sera.
    Manning-Zweerink M; Maloney CS; Mitchell TG; Weston H
    J Clin Microbiol; 1986 Jan; 23(1):46-52. PubMed ID: 2422198
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cross-reacting Candida albicans antigens in the pathogenesis of candidiasis].
    Karaev ZO; Lebedeva TN; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Oct; (10):106-9. PubMed ID: 1706123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Use of cross-reacting microbial antigens reversal of tolerance acquired for mouse transplantation antigens].
    Ogurtsov RP
    Biull Eksp Biol Med; 1976 Sep; 82(9):1104-6. PubMed ID: 791393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunisation with the glycolytic enzyme enolase confers effective protection against Candida albicans infection in mice.
    Li Wq; Hu Xc; Zhang X; Ge Y; Zhao S; Hu Y; Ashman RB
    Vaccine; 2011 Jul; 29(33):5526-33. PubMed ID: 21645574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental use of antilymphocytic serum and microbial antigens cross-reacting with mammalian tissues to produce and abolish tolerance to transplantation antigens.
    Ogurtsov RP; Karasik OA
    Bull Exp Biol Med; 1974 Dec; 77(6):650-2. PubMed ID: 4613409
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cellular immunologic reactions in mice tolerant to the transplantation antigens after immunization with the cross-reacting microbial antigens].
    Ogurtsov RP
    Zh Mikrobiol Epidemiol Immunobiol; 1978 Apr; (4):62-7. PubMed ID: 358695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Streptococcal immunoglobulin Fc reception and its participation in poststreptococcal complications].
    Burova LA; Totolian AA; Christensen P; Schalén C
    Zh Mikrobiol Epidemiol Immunobiol; 1984 Oct; (10):12-20. PubMed ID: 6395582
    [No Abstract]   [Full Text] [Related]  

  • 15. Cross-reacting human and rabbit antibodies to antigens of Histoplasma capsulatum, Candida albicans, and Saccharomyces cerevisiae.
    Kumar BV; Medoff G; Kobayashi GS; Sieling WL
    Infect Immun; 1985 Jun; 48(3):806-12. PubMed ID: 3888844
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of Candida sp. mannan antigen by indirect ELISA-inhibition. In vitro crossed reactivity among mannans obtained from C. albicans A, C. albicans B, and C. tropicalis.
    Garcia-de-Lomas J; Morales C; Grau MA; Mir A
    Mycopathologia; 1988 Jun; 102(3):175-8. PubMed ID: 3050526
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Humoral immune responses to systemic Candida albicans infection in inbred mouse strains.
    Costantino PJ; Gare NF; Warmington JR
    Immunol Cell Biol; 1995 Apr; 73(2):125-33. PubMed ID: 7797232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody formation in experimental immunizations with Candida albicans ribosomal fractions.
    Segal E; Levy R; Eylan E
    Mycopathologia; 1978 Oct; 64(2):121-3. PubMed ID: 366424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological cross reactivity between Candida albicans and human tissue.
    Vojdani A; Rahimian P; Kalhor H; Mordechai E
    J Clin Lab Immunol; 1996; 48(1):1-15. PubMed ID: 10332630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Some mechanisms of immunopathological damage].
    Zubzhitskiĭ IuN
    Vestn Akad Med Nauk SSSR; 1971; 26(3):88-91. PubMed ID: 4931991
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.